An Immune-Related Gene Expression Profile to Predict the Efficacy of Adding Atezolizumab to First-Line FOLFOXIRI Plus Bevacizumab in Metastatic Colorectal Cancer: A Translational Analysis of the Phase II Randomized AtezoTRIBE Study.